相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Su1915 Prediction of Anti-TNF Antibody Responses in Crohn's Disease by Endoscopic Molecular Imaging In Vivo: A Clinical Phase 1 Study
Raja Atreya et al.
GASTROENTEROLOGY (2015)
Review article: the role of anti-TNF in the management of ulcerative colitis past, present and future
S. Danese et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells
Andreas Fischer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Regulation of wound healing and organ fibrosis by toll-like receptors
Peter Huebener et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer Preparing for the Future
Philippe Fournier et al.
BIODRUGS (2013)
A Single Strain of Clostridium butyricum Induces Intestinal IL-10-Producing Macrophages to Suppress Acute Experimental Colitis in Mice
Atsushi Hayashi et al.
CELL HOST & MICROBE (2013)
Drug monitoring of biologics in inflammatory bowel disease
Alexander Eser et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
TNFR2 Activates MLCK-Dependent Tight Junction Dysregulation to Cause Apoptosis-Mediated Barrier Loss and Experimental Colitis
Liping Su et al.
GASTROENTEROLOGY (2013)
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Paul J. Rutgeerts et al.
GUT (2013)
Biosimilars in IBD: hope or expectation?
Krisztina B. Gecse et al.
GUT (2013)
Neutralization of Membrane TNF, but Not Soluble TNF, Is Crucial for the Treatment of Experimental Colitis
Clementine Perrier et al.
INFLAMMATORY BOWEL DISEASES (2013)
Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity
Eugen Musch et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mucin Function in Inflammatory Bowel Disease An Update
Doron Boltin et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis
V. Valatas et al.
MUCOSAL IMMUNOLOGY (2013)
Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
A. E. Dorofeyev et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
p53 Mediates TNF-Induced Epithelial Cell Apoptosis in IBD
Tatiana Goretsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Autophagy and the Immune System
Petric Kuballa et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Modulation of Anti-Tumor Necrosis Factor Alpha (TNF-α) Antibody Secretion in Mice Immunized with TNF-α Kinoid
Eric Assier et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
I. Monteleone et al.
CURRENT MOLECULAR MEDICINE (2012)
Common alleles that influence autophagy and the risk for inflammatory bowel disease
Agnes Gardet et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Colitis and Colorectal Cancer
Sebastian Foersch et al.
DIGESTIVE DISEASES (2012)
Inflammatory Bowel Disease: Dysfunction of Autophagy?
Michael Scharl et al.
DIGESTIVE DISEASES (2012)
Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation
Shila Gilbert et al.
EMBO MOLECULAR MEDICINE (2012)
A review and expert opinion of the use of certolizumab for Crohn's disease
Ashley T. Evans et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid-Refractory Ulcerative Colitis
Bruce E. Sands et al.
GASTROENTEROLOGY (2012)
Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
Cosimo Prantera et al.
GASTROENTEROLOGY (2012)
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
Pierre Desreumaux et al.
GASTROENTEROLOGY (2012)
Abatacept for Crohn's Disease and Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro
Anne Christine W. Vos et al.
INFLAMMATORY BOWEL DISEASES (2012)
Healing of intestinal inflammation by IL-22
Atsushi Mizoguchi
INFLAMMATORY BOWEL DISEASES (2012)
Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study
Asit Parikh et al.
INFLAMMATORY BOWEL DISEASES (2012)
Changing Crohn's disease management: Need for new goals and indices to prevent disability and improve quality of life
Daniel Hommes et al.
Journal of Crohns & Colitis (2012)
Mucins in inflammatory bowel diseases and colorectal cancer
Yong H. Sheng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Innate immune dysfunction in inflammatory bowel disease
M. Gersemann et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
Nina A. Hering et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion
Marie-Agnes Bringer et al.
LABORATORY INVESTIGATION (2012)
Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
Giovanni Monteleone et al.
MOLECULAR THERAPY (2012)
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy
S. Danese et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Epithelial Barriers in Intestinal Inflammation
Lena J. John et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Th17-related cytokines: new players in the control of chronic intestinal inflammation
Ivan Monteleone et al.
BMC MEDICINE (2011)
We Once Were Blind and Now We See: Is it Time to Treat Ulcerative Colitis to Achieve Mucosal Healing?
David T. Rubin
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation
Wei Liao et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Interleukin-13 Damages Intestinal Mucosa via TWEAK and Fn14 in Mice-A Pathway Associated With Ulcerative Colitis
Rei Kawashima et al.
GASTROENTEROLOGY (2011)
Anti-Tumor Necrosis Factor-alpha Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
Anne Christine W. Vos et al.
GASTROENTEROLOGY (2011)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell-Dependent Colitis
Stefan Wirtz et al.
GASTROENTEROLOGY (2011)
Characterization of Interleukin-17-Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases
Zaruhi Hovhannisyan et al.
GASTROENTEROLOGY (2011)
Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
Raja Atreya et al.
GASTROENTEROLOGY (2011)
Intestinal Growth Factors: Potential Use in the Treatment of Inflammatory Bowel Disease and Their Role in Mucosal Healing
Kumar Krishnan et al.
INFLAMMATORY BOWEL DISEASES (2011)
Long-term Complications, Extraintestinal Manifestations, and Mortality in Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae
Benoit Chassaing et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
IL-27 promotes T cell-dependent colitis through multiple mechanisms
Jennifer H. Cox et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
Carmine Stolfi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Minireview: Glucocorticoids in Autoimmunity: Unexpected Targets and Mechanisms
Jamie R. Flammer et al.
MOLECULAR ENDOCRINOLOGY (2011)
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Claudia Guenther et al.
NATURE (2011)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Transcriptome of Trichuris suis - First Molecular Insights into a Parasite with Curative Properties for Key Immune Diseases of Humans
Cinzia Cantacessi et al.
PLOS ONE (2011)
The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions
Malin E. V. Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
ADAM17: a molecular switch to control inflammation and tissue regeneration
Juergen Scheller et al.
TRENDS IN IMMUNOLOGY (2011)
Wound healing of intestinal epithelial cells
Masahiro Iizuka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Saskia Thomas et al.
INFLAMMOPHARMACOLOGY (2011)
Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
Daniela De Nitto et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Phosphatidylcholine (Lecithin) and the Mucus Layer: Evidence of Therapeutic Efficacy in Ulcerative Colitis?
Wolfgang Stremmel et al.
DIGESTIVE DISEASES (2010)
Predicting the response to infliximab from trough serum levels
Paul Rutgeerts et al.
GUT (2010)
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease
Iris Dotan et al.
GUT (2010)
T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells
Claudia Hofmann et al.
GUT (2010)
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis
William J. Sandborn et al.
GUT (2010)
Fontolizumab in Moderate to Severe Crohn's Disease: A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2010)
Granulocyte-Macrophage Colony-Stimulating Factor Elicits Bone Marrow-Derived Cells that Promote Efficient Colonic Mucosal Healing
Eric Bernasconi et al.
INFLAMMATORY BOWEL DISEASES (2010)
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
K. Vandenbroucke et al.
MUCOSAL IMMUNOLOGY (2010)
Clinical implications of mucosal healing for the management of IBD
Guillaume Pineton de Chambrun et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression
Massimo C. Fantini et al.
GASTROENTEROLOGY (2009)
Colitis-Associated Variant of TLR2 Causes Impaired Mucosal Repair Because of TFF3 Deficiency
Daniel K. Podolsky et al.
GASTROENTEROLOGY (2009)
ROR gamma-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
Moritz Leppkes et al.
GASTROENTEROLOGY (2009)
Regulation of intestinal barrier function by signal transducer and activator of transcription 5b
X. Han et al.
GUT (2009)
Selective targeting of activated T cells in chronic intestinal inflammation
Benno Weigmann et al.
GUT (2009)
Adalimumab Safety in Global Clinical Trials of Patients with Crohn's Disease
Jean-Frederic Colombel et al.
INFLAMMATORY BOWEL DISEASES (2009)
Intestinal Barrier Dysfunction in Inflammatory Bowel Diseases
Michael A. McGuckin et al.
INFLAMMATORY BOWEL DISEASES (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
CCR6 Regulation of the Actin Cytoskeleton Orchestrates Human Beta Defensin-2-and CCL20-mediated Restitution of Colonic Epithelial Cells
Rebecca A. Vongsa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TLR2 Mediates Gap Junctional Intercellular Communication through Connexin-43 in Intestinal Epithelial Barrier Injury
Birgit Ey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
Melanie A. Kleinschek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Geethanjali Pickert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Efficient colonic mucosal wound repair requires Trem2 signaling
Hiroshi Seno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tocilizumab: An Interleukin-6 Receptor Inhibitor for the Treatment of Rheumatoid Arthritis
Susyn L. Plushner
ANNALS OF PHARMACOTHERAPY (2008)
Signaling molecules: The pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer
R. Atreya et al.
CURRENT DRUG TARGETS (2008)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
T. Kobayashi et al.
GUT (2008)
Galectin-2 and -4, But Not Galectin-1, Promote Intestinal Epithelial Wound Healing In Vitro Through a TGE-beta-independent Mechanism
Daniela Paclik et al.
INFLAMMATORY BOWEL DISEASES (2008)
Human beta defensin 2 promotes intestinal wound healing in vitro
Jan-Michel Otte et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
TGF-β1 and Smad7 in the regulation of IBD
G. Monteleone et al.
MUCOSAL IMMUNOLOGY (2008)
The role of IL-13 and NK T cells in experimental and human ulcerative colitis
I. J. Fuss et al.
MUCOSAL IMMUNOLOGY (2008)
Epithelial restitution and wound healing in inflammatory bowel disease
Andreas Sturm et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia
Rebecca A. Moyer et al.
LABORATORY INVESTIGATION (2007)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Arianna Nenci et al.
NATURE (2007)
Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease
Jan M. H. Van den Brande et al.
GUT (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis
Jongdae Lee et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-β1-mediated suppression of colitis
Monica Boirivant et al.
GASTROENTEROLOGY (2006)
Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells
Jongdae Lee et al.
NATURE CELL BIOLOGY (2006)
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis
Holm H. Uhlig et al.
JOURNAL OF IMMUNOLOGY (2006)
Cysteine-rich domains of Muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing
Samuel B. Ho et al.
GASTROENTEROLOGY (2006)
Interleukin-23 drives innate and T cell-mediated intestinal inflammation
Sophie Hue et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn's disease
W. Reinisch et al.
GUT (2006)
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation
Ana Izcue et al.
IMMUNOLOGICAL REVIEWS (2006)
Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis
MC Fantini et al.
GUT (2006)
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
C Prantera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease
KR Herllinger et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Azathioprine suppresses ezrin-radixin-moesin-dependent T Cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac protein
D Poppe et al.
JOURNAL OF IMMUNOLOGY (2006)
Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
IJ Fuss et al.
INFLAMMATORY BOWEL DISEASES (2006)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Reduced Paneth cell α-defensins in ileal Crohn's disease
J Wehkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Natalizumab induction and maintenance therapy for Crohn's disease
WJ Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
G Van Assche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
W Stremmel et al.
GUT (2005)
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis
M Fukata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Trichuris suis therapy for active ulcerative colitis:: A randomized controlled trial
RW Summers et al.
GASTROENTEROLOGY (2005)
T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells
L Fahlén et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Toll-like receptor 9-induced type IIFN protects mice from experimental colitis
K Katakura et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-α
H Mitoma et al.
GASTROENTEROLOGY (2005)
Trichuris suis therapy in Crohn's disease
RW Summers et al.
GUT (2005)
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis
IJ Fuss et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Immune responses
KM Pickard et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2004)
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
H Ito et al.
GASTROENTEROLOGY (2004)
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
D Rachmilewitz et al.
GASTROENTEROLOGY (2004)
Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor α antibody treatment
S Zeissig et al.
GUT (2004)
Anti-interleukin-12 antibody for active Crohn's disease
PJ Mannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker et al.
IMMUNITY (2004)
CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile
KA Papadakis et al.
JOURNAL OF IMMUNOLOGY (2003)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease
JMH Van Den Brande et al.
GASTROENTEROLOGY (2003)
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
NH Salzman et al.
NATURE (2003)
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
I Tiede et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Tumor necrosis factor signaling
H Wajant et al.
CELL DEATH AND DIFFERENTIATION (2003)
Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells
F Heller et al.
IMMUNITY (2002)
The role of Th1/Th2 polarization in mucosal immunity
MF Neurath et al.
NATURE MEDICINE (2002)
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease
MF Neurath et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis
D Rachmilewitz et al.
GASTROENTEROLOGY (2002)
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
WJ Sandborn et al.
GASTROENTEROLOGY (2001)
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
RN Fedorak et al.
GASTROENTEROLOGY (2000)
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
分享论文
